Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparative study of clinical grade human tolerogenic dendritic cells.

Journal of translational medicine - 9 Jun 2011

Naranjo-Gómez M, Raïch-Regué D, Oñate C, Grau-López L, Ramo-Tello C, Pujol-Borrell R, Martínez-Cáceres E, Borràs Francesc E

Abstract excerpt

BACKGROUND: The use of tolerogenic DCs is a promising therapeutic strategy for transplantation and autoimmune disorders. Immunomodulatory DCs are primarily generated from monocytes (MDDCs) for in vitro experiments following protocols that fail to fulfil the strict regulatory rules of clinically applicable products. Here, we compared the efficacy of three different tolerance-inducing agents, dexamethasone,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents
Share to Cholecalciferol

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dendritic Cells

Share to Dexamethasone

Share to Forkhead Transcription Factors

Share to Immune Tolerance

Share to Sirolimus

Share to Th1 Cells

Source

Open in PubMed Open full text

Identifiers

PMID: 21658226
DOI: 10.1186/1479-5876-9-89
PMCID: PMC3141500

Genes

TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparative study of clinical grade human tolerogenic dendritic cells.PMID 21658226Read ↗

A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines.Semantic proximity Read ↗

IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction--a comparative study of human clinical-applicable DC.Semantic proximity Read ↗

Handbook of experimental pharmacology "dendritic cells": the use of dexamethasone in the induction of tolerogenic DCs.Semantic proximity Read ↗

Gram-negative enterobacteria induce tolerogenic maturation in dexamethasone conditioned dendritic cells.Semantic proximity Read ↗

Type 1 regulatory T cells and regulatory B cells induced by tolerogenic dendritic cells.Semantic proximity Read ↗

Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials.Semantic proximity Read ↗

Th1-polarizing capacity of clinical-grade dendritic cells is triggered by Ribomunyl but is compromised by PGE2: the importance of maturation cocktails.Semantic proximity Read ↗

Comparison of two different protocols for the induction of maturation of human dendritic cells in vitro.Semantic proximity Read ↗

Antithymocyte Globulin Induces a Tolerogenic Phenotype in Human Dendritic Cells.Semantic proximity Read ↗

Modulatory effect of rapamycin and tacrolimus on monocyte-derived dendritic cells phenotype and function.Semantic proximity Read ↗

Differential protein pathways in 1,25-dihydroxyvitamin d(3) and dexamethasone modulated tolerogenic human dendritic cells.Semantic proximity Read ↗

Immunosuppressive agents mediate reduced allostimulatory properties of myeloid-derived dendritic cells despite induction of divergent molecular phenotypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.